Onyx Pharmaceuticals (ONXX) Misses Q2 EPS Views; Revs Light
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q2 EPS of ($0.43), $0.30 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $67.96 million versus the consensus estimate of $74.72 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
